Insulet Corporation (NASDAQ:PODD) is one of the best growth stocks to buy in 2026. On December 18, Truist lowered the firm’s price target on Insulet to $390 from $412 with a Buy rating on the shares.

Insulet (PODD) has been quietly recalibrating after a choppy past month, with the stock down around 11% even as its year to date gain sits in the mid teens, inviting a closer look. See our latest ...

Fintel reports that on December 18, 2025, Truist Securities maintained coverage of Insulet (NasdaqGS:PODD) with a Buy recommendation. Analyst Price Forecast Suggests 31.68% Upside As of December 5, ...

Emily Henry's bestselling "People We Meet on Vacation" has officially hit the screen. Here are the biggest differences ...

Tayari Jones, Ann Patchett, George Saunders and Veronica Roth return with new novels; Jennette McCurdy makes her fiction debut; and more. By Miguel Salazar and Laura Thompson Reading recommendations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Tayari Jones, Ann Patchett, George Saunders and Veronica Roth return with new novels; Jennette McCurdy makes her fiction debut; and more. By Miguel Salazar and Laura Thompson In “Advance Britannia,” ...

Communications Biology is an open access journal from Nature Portfolio publishing high-quality research, reviews and commentary in all areas of the biological sciences. Research papers published by ...

Several best-selling books will make way for returning TV shows and new ones in 2026. One of the first major arrivals in January will be A Knight of the Seven Kingdoms, based on George R. R. Martin’s ...

L-R: Margot Robbie in 'Wuthering Heights,' Matt Damon in 'The Odyssey' and Ryan Gosling in 'Project Hail Mary' Warner Bros, Universal, Amazon MGM Many books will provide backbone to both theatrical ...